Alzheimer's disease: clinical features, pathogenesis, and treatment. 1984.
Rathmann
Kaye L
KL
Conner
Christopher S
CS
D000544:Alzheimer Disease / Q000188:drug therapy / Q000209:etiology / Q000266:history* / Q000473:pathology; D000818:Animals; D018678:Cholinergic Agents / Q000266:history / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000266:history / Q000627:therapeutic use; D049673:History, 20th Century; D006801:Humans; D009270:Naloxone / Q000266:history / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000266:history / Q000627:therapeutic use; D010830:Physostigmine / Q000266:history / Q000627:therapeutic use
D018678:Cholinergic Agents; D002800:Cholinesterase Inhibitors; D009292:Narcotic Antagonists; D009270:Naloxone; D010830:Physostigmine